Kestra Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113M Buy
122,730
+14,606
+14% +$14.8M 0.43% 32
2025
Q4
$116M Buy
108,124
+17,806
+20% +$17M 0.48% 28
2025
Q3
$68.9M Buy
90,318
+4,938
+6% +$3.67M 0.32% 51
2025
Q2
$66.6M Buy
85,380
+1,160
+1% +$901K 0.32% 47
2025
Q1
$69.6M Buy
84,220
+1,300
+2% +$1.08M 0.34% 36
2024
Q4
$64M Sell
82,920
-3,633
-4% -$3.01M 0.35% 52
2024
Q3
$76.7M Sell
86,553
-3,968
-4% -$3.57M 0.42% 35
2024
Q2
$77.5M Buy
90,521
+14,841
+20% +$11.9M 0.43% 33
2024
Q1
$58.9M Buy
75,680
+10,359
+16% +$7.37M 0.39% 36
2023
Q4
$38.1M Buy
65,321
+6,343
+11% +$3.7M 0.31% 57
2023
Q3
$31.7M Buy
58,978
+1,531
+3% +$789K 0.31% 58
2023
Q2
$26.9M Buy
57,447
+342
+0.6% +$143K 0.27% 73
2023
Q1
$19.6M Sell
57,105
-16,527
-22% -$5.57M 0.21% 106
2022
Q4
$26.9M Buy
73,632
+7,786
+12% +$2.76M 0.24% 92
2022
Q3
$21.3M Sell
65,846
-10,150
-13% -$3.22M 0.23% 97
2022
Q2
$24.6M Buy
75,996
+24,058
+46% +$7.22M 0.25% 85
2022
Q1
$14.9M Buy
51,938
+3,883
+8% +$999K 0.15% 146
2021
Q4
$13.3M Buy
48,055
+2,917
+6% +$739K 0.13% 174
2021
Q3
$10.4M Sell
45,138
-1,428
-3% -$352K 0.1% 213
2021
Q2
$10.7M Buy
46,566
+1,493
+3% +$300K 0.12% 191
2021
Q1
$8.42M Sell
45,073
-17,525
-28% -$3.43M 0.11% 222
2020
Q4
$10.5M Buy
62,598
+18,467
+42% +$2.76M 0.12% 196
2020
Q3
$6.53M Buy
+44,131
New +$6.83M 0.12% 202

Other funds holding LLY

Kestra Advisory Services's LLY Position: Q1 2026 in Review

Kestra Advisory Services increased its Eli Lilly (LLY) stake by 14% in Q1 2026, buying an estimated $14.8M and bringing the position to 122,730 shares worth $113M. The position accounts for 0.43% of the portfolio, ranked #32.

Kestra Advisory Services first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $116M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kestra Advisory Services held 122,730 shares of Eli Lilly worth $113M as of Q1 2026.
  • Kestra Advisory Services bought 14,606 Eli Lilly shares in Q1 2026, an estimated $14.8M.
  • Eli Lilly made up 0.43% of Kestra Advisory Services's portfolio in Q1 2026, its #32 holding.
  • Kestra Advisory Services first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's Eli Lilly position peaked at $116M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.